Core Viewpoint - Hyatt Hotels Corporation is expected to report a decline in earnings and revenues for the first quarter of 2025, with significant factors influencing its performance, including room additions and market demand [1][2][3]. Financial Performance - The Zacks Consensus Estimate for first-quarter earnings per share (EPS) is 30 cents, reflecting a 57.8% decrease from 71 cents in the same quarter last year [1]. - Revenue is projected at nearly $1.7 billion, indicating a 0.7% decline from the previous year's quarter [2]. Factors Influencing Results - Hyatt's performance is anticipated to benefit from accelerated net room additions and strategic expansion in the all-inclusive and luxury segments [3]. - Sustained demand from high-end travelers and increased corporate travel activity are expected to enhance revenue per available room [4]. - Strong contributions from franchise and other fees, as well as base and incentive fees, are likely to support performance, with gross fees predicted to rise 13.9% year over year to $298.5 million [5]. - The expanding loyalty base, World of Hyatt, along with strong credit card spending and brand engagement, is expected to bolster commercial performance [6]. Challenges - Inflationary pressures, rising labor costs in certain markets, and the impact of asset sales completed in 2024 may negatively affect Hyatt's bottom line, with an expected adjusted EBITDA impact of approximately $40 million due to real estate dispositions [7]. Earnings Prediction - The current model does not predict an earnings beat for Hyatt, as it has an Earnings ESP of -25.21% and a Zacks Rank of 3 [8].

Core Viewpoint - Barclays is expected to report an increase in quarterly revenues and earnings for Q1 2025, driven by improved trading performance and net interest income, despite challenges in investment banking revenues and rising credit impairment charges [1][3][7]. Group 1: Earnings and Revenue Expectations - The Zacks Consensus Estimate for Barclays' earnings is 61 cents per share, reflecting a 17.3% increase year-over-year, with sales expected to reach $10.07 billion, indicating a 14.2% growth [2]. - The company recorded a rise in credit impairment charges in the last quarter, which may impact overall profitability [1]. Group 2: Investment Banking Performance - Global M&A activity in Q1 2025 was less impressive than anticipated, with marginal increases in deal value and volume, primarily driven by the Asia Pacific region [3]. - Economic uncertainty, influenced by tariff policy ambiguity and rising inflation, has led companies to reconsider their M&A plans, resulting in only marginal growth in advisory fees for Barclays [3]. Group 3: Trading and Market Activity - Client activity and market volatility were strong in Q1, with high volatility across equity markets and other asset classes, which is expected to positively impact Barclays' trading performance [5][6]. - The company is anticipated to see robust performance in its trading business due to solid client activity amid market volatility [6]. Group 4: Net Interest Income and Expenses - Barclays' net interest income is expected to improve due to a mixed approach to interest rate adjustments by central banks, leading to stabilized funding costs and increased loan demand [7]. - Cost control measures have resulted in improved efficiency, with expenses expected to remain manageable due to ongoing business restructuring initiatives [8].

Core Viewpoint - FMC Corporation is expected to report its first-quarter 2025 results on April 30, with a history of beating earnings estimates and a trailing four-quarter earnings surprise of approximately 20.2% [1][4] Earnings Performance - FMC has consistently exceeded Zacks Consensus Estimates for earnings in the last four quarters, with an earnings surprise of 11.1% in the most recent quarter [1][2] - The Earnings ESP for FMC is +34.04%, indicating a strong likelihood of an earnings beat this quarter [4] Revenue Estimates - The Zacks Consensus Estimate for FMC's first-quarter sales is $779 million, reflecting a 15.1% year-over-year decline [7] - Revenue estimates for different regions include: - North America: $224.2 million, a 13.4% decline [7] - Latin America: $137.9 million, a 26.6% decline [7] - EMEA: $278.5 million, a 9.2% decline [8] - Asia: $144.8 million, an 11.8% decline [8] Factors Influencing Performance - FMC is expected to benefit from new product launches and cost-control measures, which are anticipated to support its performance despite challenges [2][9] - The company is focusing on expanding its product portfolio and has seen strong sales from its growth portfolio, including new active ingredients [9] - Cost reductions and a favorable product mix are expected to positively impact margins, with restructuring actions projected to yield $165 million in adjusted EBITDA for full-year 2024 and over $225 million in savings by the end of 2025 [10] Challenges Faced - FMC is likely to encounter challenges from inventory de-stocking and pricing pressures, which may negatively affect volumes and revenues [11][12] - The company projects first-quarter revenues in the range of $750-$800 million, indicating a 16% decrease at the midpoint compared to the same period in 2024 [11] - Weaker prices are expected to continue impacting revenues, with a mid-to-high single-digit price decline anticipated due to adjustments in partner contracts [12]

Albemarle Corporation (ALB) is slated to release first-quarter 2025 results after the closing bell on April 30.The company missed the Zacks Consensus Estimate for earnings in each of the trailing four quarters. In this timeframe, it delivered a negative earnings surprise of 160.2%, on average. It posted a negative earnings surprise of 122.5% in the last reported quarter. ALB is likely to have benefited from its cost and productivity actions in the first quarter amid headwinds from softer lithium market pric ...

The Hanover Insurance Group (THG) is expected to register an improvement in its top and bottom lines when it reports first-quarter 2025 results on April 30, after the closing bell.The Zacks Consensus Estimate for THG’s first-quarter revenues is pegged at $1.7 billion, indicating a 6.5% increase from the year-ago reported figure. The consensus estimate for the bottom line is pegged at $3.58 per share. The estimate suggests a year-over-year increase of 144.4%. The Zacks Consensus Estimate for THG’s first-quar ...

Core Insights - The U.S. construction sector is experiencing a deceleration, influenced by high borrowing costs, labor shortages, material price volatility, and regulatory complexity [1] Group 1: Sector Performance - Public sector investments in infrastructure and manufacturing have supported growth, while residential remodeling and selective new home construction have posed challenges [1] - The construction sector's total earnings have decreased by 20% year-over-year, with revenues down by 4.2% [2] - Approximately 35.3% of the construction sector's market capitalization on the S&P 500 Index has reported earnings, with 57.1% beating EPS estimates and 42.9% surpassing revenue estimates [2] Group 2: Influencing Factors - Federal spending through the Infrastructure Investment and Jobs Act (IIJA) has been a significant tailwind, particularly in transportation, water infrastructure, and broadband projects [3] - Industrial construction projects related to the CHIPS Act and Inflation Reduction Act have also contributed to growth, focusing on semiconductor fabs, EV battery plants, and clean energy facilities [3] Group 3: Residential Market Challenges - The residential construction market faces high mortgage rates, seasonal impacts, inflationary pressures, and rising costs, which have negatively affected performance [4] - Homebuilders are under pressure due to increased incentives and lower average selling prices, impacting margins [4] Group 4: Commercial Construction Insights - The commercial construction market shows mixed but resilient performance, with industrial and warehouse projects benefiting from e-commerce and supply chain reshoring [5] - Data center construction is gaining traction due to cloud computing and AI infrastructure needs, while hospitality construction is recovering alongside rebounding travel [5] Group 5: Q1 Earnings Expectations - The construction sector is expected to see a 12.8% decline in earnings for Q1, a decrease from the previous quarter's growth of 1.1% [6] - Revenues are projected to decline by 3.3%, indicating a slowdown from the prior quarter's growth of 1.6% [6] Group 6: Company Highlights - Dream Finders Homes is expected to report a first-quarter EPS of 61 cents, reflecting a 10.9% growth year-over-year [11] - Primoris Services anticipates a first-quarter EPS of 72 cents, representing a 53.2% increase from the previous year [13] - Potlatch is projected to report a first-quarter EPS of 20 cents, improving from break-even earnings a year ago [14] - Martin Marietta Materials expects a first-quarter EPS of $1.92, a slight decline from the previous year [15] - MasTec is likely to report a first-quarter EPS of 34 cents, indicating a significant 361.5% growth year-over-year [16]

Core Viewpoint - Caterpillar Inc. is expected to report year-over-year declines in both earnings and revenues for the first quarter of 2025, with earnings estimated at $4.30 per share, reflecting a 23% decline from the previous year, and revenues projected at $14.54 billion, indicating an 8% decrease [1]. Financial Estimates - The Zacks Consensus Estimate for Q1 2025 earnings has decreased by 0.46% over the past 60 days [2]. - The current earnings estimate for Q1 is $4.30, down from $4.33 30 days ago, and the revenue estimate is $14.54 billion [2]. - The operating income is projected to decrease by 25% year-over-year to $2.55 billion, with an operating margin of 18.8%, down from 22.8% in Q4 2024 [10]. Segment Performance - The Resource Industries segment is expected to report external sales of $2.72 billion, a 12% decline year-over-year, with an operating profit of $621 million, down 15% [11]. - The Construction segment's external sales are projected at $5.38 billion, reflecting a 16% decline, with an operating profit of $1.39 billion, indicating a 21% decrease [12]. - The Energy and Transportation segment is expected to see external sales of $5.5 billion, a slight increase of 0.5%, with an operating profit of $1.3 billion, down 0.3% year-over-year [14][15]. Market Conditions - The manufacturing sector showed initial signs of recovery in early 2025 but lost momentum, as indicated by the Institute for Supply Management's manufacturing index, which fell to 49% in March [6]. - The New Orders Index declined sharply from 55.1% in January to 45.2% in March, reflecting reduced customer orders due to rising tariff concerns [7]. Price Performance and Valuation - Caterpillar's stock has decreased by 12.4% over the past year, underperforming its industry and the broader market [16]. - The stock is currently trading at a forward P/E of 15.64, which is higher than the industry average of 14.79 [20]. - Compared to peers like Komatsu, Terex, and Manitowoc, Caterpillar's valuation is relatively high, with competitors trading at lower P/E ratios [21]. Strategic Outlook - Long-term demand prospects for Caterpillar are supported by increased infrastructure spending and a shift toward clean energy [25]. - The company has a strong balance sheet, allowing for investments in growth, share repurchases, and dividends [25]. - The upcoming leadership change with COO Joseph Creed succeeding James Umpleby as CEO will be closely monitored for its impact on navigating current challenges [25].

Industry Overview - The first-quarter earnings season for the drug and biotech sector is underway, with major companies like Pfizer, Eli Lilly, Amgen, Biogen, and Regeneron set to announce results [1] - Johnson & Johnson and Merck have reported results, both exceeding first-quarter estimates for earnings and sales, while Sanofi had mixed results, beating earnings estimates but missing sales [1] Earnings Trends - As of April 23, 15% of companies in the Medical sector, representing 33.8% of the sector's market capitalization, reported quarterly earnings, with 77.8% surpassing estimates for both earnings and revenues [3] - Year-over-year earnings increased by 4.7%, and revenues rose by 9.4% [3] - Overall, first-quarter earnings for the Medical sector are expected to increase by 35%, while sales are projected to rise by 7.8% compared to the previous year [3] Company Performance Pfizer (PFE) - Pfizer has consistently exceeded earnings expectations in the last four quarters, with an average earnings surprise of 44.16% [5] - The Zacks Consensus Estimate for first-quarter sales and earnings is $13.88 billion and 64 cents per share, respectively [6] - Non-COVID operational revenues are driving growth, supported by products like Vyndaqel, Padcev, and Eliquis, despite a decline in sales of COVID products [7] Eli Lilly (LLY) - Eli Lilly has had mixed performance, exceeding earnings expectations in three of the last four quarters, with an average earnings surprise of 8.47% [8] - The Zacks Consensus Estimate for sales and earnings is $12.62 billion and $3.52 per share, respectively [8] - Growth is expected to be driven by demand for FDA-approved tirzepatide medicines, although sales of Mounjaro and Zepbound were below expectations [9][10] Amgen (AMGN) - Amgen has shown strong performance, beating earnings estimates in each of the last four quarters, with an average earnings surprise of 5.23% [11] - The Zacks Consensus Estimate for first-quarter sales and earnings is $7.96 billion and $4.15 per share, respectively [11] - Product sales are expected to be driven by strong volume growth, although prices may decline due to higher rebates [12] Biogen (BIIB) - Biogen has consistently beaten earnings estimates in the last four quarters, with an average earnings surprise of 11.80% [13] - The Zacks Consensus Estimate for sales and earnings is $2.23 billion and $3.52 per share, respectively [13] - Lower sales of multiple sclerosis drugs are likely to be offset by revenues from new drugs [14] Regeneron (REGN) - Regeneron has had mixed results, surpassing earnings expectations in three of the last four quarters, with an average earnings surprise of 3.23% [16] - The Zacks Consensus Estimate for first-quarter sales and earnings is $3.28 billion and $8.43 per share, respectively [17] - Sales of Eylea are expected to have declined due to competition, but sales of Eylea HD and Dupixent are likely to have surged [18][19]

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Essential Utilities (WTRG) , which belongs to the Zacks Utility - Water Supply industry, could be a great candidate to consider.This water utility has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 5.11%.For the most recent quarter, Essential Util ...

Amcor Plc (AMCR) is scheduled to report third-quarter fiscal 2025 results on April 30, after the closing bell.The Zacks Consensus Estimate for AMCR’s fiscal third-quarter revenues is pegged at $3.51 billion, indicating 2.9% growth from the year-ago reported figure.The consensus estimate for earnings is pegged at 18 cents per share. The consensus estimate indicates in-line results with the year-ago quarter. The estimate has moved down 5.3% in the past 60 days.  Image Source: Zacks Investment Research AMCR’s ...